Preexisting dementia in stroke patients: Baseline frequency, associated factors, and outcome

Stroke

Volumn 28, Issue 12, 1997, Pages 2429-2436

  Henon H ^b   Pasquier, F ^a   Durieu, I ^b   Godefroy, O ^b   Lucas, C ^b   Lebert, F ^b   Leys, D ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Alzheimer's disease; Dementia; Intracerebral hemorrhage; Stroke, acute; Stroke, ischemic

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COGNITION; COHORT ANALYSIS; DEMENTIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 0344878894     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.12.2429     Document Type: Article

References (68)

1. Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA. Dementia in stroke survivors in the Stroke Data Bank cohort: prevalence, incidence, risk factors, and computed tomographic findings. Stroke. 1990;21:858-866.
2. Pasquier F, Lebert F, Petit H. Dementia, apathy and thalamic infarcts. Neuropsychiatr Neuropsychol Behav Neurol. 1995;8: 208-214.
3. Hénon H, Durieu I, Lucas C, Godefroy O, Pasquier F, Leys D. Prevalence of preexisting dementia in consecutive stroke patients. Neurology. 1996;47:852-853. Letter.
4. Frisoni G, Geroldi C, Blanquetti A, Trabucchi M, Govoni S, Francheschini G, Calebresi L. Apolipoprotein e4 allele frequency in vascular dementia and Alzheimer's disease. Stroke. 1994;25:1703. Letter.
5. Gerdes LU. Apolipoprotein E genotypes and cardiovascular disease: a quantitative overview of 42 studies. Genet Epidemiol. 1994;11:294.
6. Saunders AM, Roses AD. Apolipoprotein E allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke. 1993;24:1416. Letter.
7. Terry JG, Howard G, Mercuri M et al. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening. Stroke. 1996;27:1755-1759.
8. Ferrucci L, Guralnik JM, Salive ME, Pahor M, Corti MC, Baroni A, Havlik RJ. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc. 1996;44:237-241.
9. Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci. 1990;95:239-258.
10. Victoroff J, Mack WJ, Lyness SC, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry. 1995;152: 1476-1484.
11. Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA. Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions. Dementia. 1995;6:162-168.
12. Boone KB, Miller BL, Mehringer CM, Hill-Gutierrez E, Goldberg MA, Berman NG. Neuropsychological correlates of white-matter lesions in healty elderly subject: a threshold effect. Arch Neurol. 1992;49:549-554.
13. Erkinjuntti T, Hachinski VC. Rethinking vascular dementia. Cerebrovasc Dis. 1993;3:3-23.
14. Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J Neurol. 1997;244:135-142.
15. Tatemichi TK. How acute brain failure becomes chronic: a view of the mechanisms of dementia related to stroke. Neurology. 1990;40: 1652-1659.
16. Loeb C, Gandolfo C, Croce R, Conti M. Dementia associated with lacunar infarction. Stroke. 1992;23:1225-1229.
17. Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, Remien RH, Williams JBW, Mohr JP, Hauser WA, Figueroa M. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992;42:1185-1193.
18. Tatemichi TK, Paik M, Bagiella E, Desmond W, Stern Y, Sano M, Hauser WA, Mayeux R. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology. 1994;44: 1885-1891.
19. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minn (1960-1984). Neurology. 1996;46:154-159.
20. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia three months after stroke: baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997;28:785-792.
21. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh III EE, and the TOAST Investigators. Classification of subtypes of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-41.
22. Orgogozo JM, Calpideo R, Anagnosto CN, Juge O, Péré JJ, Dartigues JF, Steiner TJ, Yotis A, Rose FC. Mise au point d'un score neurologique pour l'évaluation clinique des infarctus sylviens. Presse Med. 1983;12:3039-3044.
23. Orgogozo JM, Dartigues JF. Methodology of clinical trials in acute trials in acute cerebral ischemia: survival, functional and neurological outcome measures. Cerebrovasc Dis. 1991:1(suppl 1): 100-111.
24. Mounier-Vehier F, Leys D, Rondepierre Ph, Godefroy O, Pruvo JP. Silent infarcts in patients with ischemic stroke are related to age and size of the left atrium. Stroke. 1993;24:1347-1351.
25. Inzitari D, Giordano GP, Ancona AL, Pracucci G, Mascalchi M, Amaducci L. Leuko-araiosis, intracerebral hemorrhage and arterial hypertension. Stroke. 1990;21:1419-1423.
26. Blennow K, Wallin A, Uhlemann C, Gottfries CG. White-matter lesions on CT in Alzheimer patients: relationship to clinical symptomatology and vascular factors. Acta Neurol Scand. 1991;83: 187-193.
27. Leys D, Pruvo JP, Petit H, Gaudet Y, Clarisse J. Maladie d'Alzheimer: analyse statistique des résultats du scanner X. Rev Neurol (Paris). 1989;145:134-139.
28. Jorm AF, Korten AE. Assessment of cognitive decline in the elderly by informant interview. Br J Psychiatry. 1988;152:209-213.
29. Jorm AF, Broe GA, Creasey H, Sulway MR, Dent O, Fairley MJ, Kos SC, Tennant C. Further data on the validity of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). Intern J Geriatric Psychiatry. 1996;11:131-139.
30. Jorm AF, Jacomb PA. The informant questionnaire on cognitive decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19: 1015-1022.
31. Jorm AF, Scott R, Cullen JS, MacKinnon AJ. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a sreening test for dementia. Psychol Med. 1991;21: 785-790.
32. Folstein MF, Folstein SE, McHugh PR. 'Mini Mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
33. Bowers J, Jorm AF, Henderson S, Harris P. General practitioner's detection of depression and dementia in elderly patients. Med J Aust. 1990;153:192-196.
34. Mulligan R, Mackinnon A, Jorm AF, Giannakopoulos P, Michel JP. A comparison of alternative methods of screening for dementia in clinical settings. Arch Neurol. 1996;23:532-536.
35. Morales JM, Gonzalez-Montalvo JI, Bermejo F, Del-Ser T. The screening of mild dementia with a shortened version on the 'Informant Questionnaire on Cognitive Decline in the Elderly.' Alzheimer Dis Assoc Disord. 1995;9:105-111.
36. Weintraub S. The record of independent living: an informant-completed measure of activities of daily living and behavior in elderly patients with cognitive impairment. Am J Alzheimer Care Related Disord. 1986;35-39.
37. Law S, Wolfson C. Validation of a French version of an informant-based questionnaire as a screening test for Alzheimer's disease. Br J Psychiatry. 1995;167:541-544.
38. Del Ser T, Morales JM, Barquero MS, Canton R, Bermelo F. Application of a Spanish version of the 'Informant Questionnaire on Cognitive Decline in the Elderly' in the clinical assessment of dementia. Alzheimer Dis Assoc Disord. 1997;11:3-8.
39. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnosis and Statistical Manual of Mental Disorders (DSM-III-R). 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987.
40. World Health Association. The International Classification of Diseases. 9th Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1981. WHO typescript document MNH/ MEP/87.1.
41. Wade DT, Skilbeck CE, Hewer RL. Predicting Barthel ADL score at 6 months after an acute stroke. Arch Phys Med Rehabil. 1983;64: 24-28.
42. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
43. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry research, 1987;23:89-97.
44. Mattis S. Mental status examination for organic mental syndrome in the elderly patients. In: Bellak L, Karasu TB, eds. Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians. New York, NY: Grune & Stratton: 1976:77-121.
45. Wechsler D. Wechsler Memory Scale: Revised Manual. San Antonio. Tex: The Psychological Corporation; 1987.
46. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci. 1987;Suppl 8:Milano: Masson Italia Periodici.
47. Reitan RM. Validity of trail making test as an indicator of organic brain damage. Percept Mot Skills. 19588;271-276.
48. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643-662.
49. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology. 1988;38:900-903.
50. Grober E, Buschke H. Genuine memory deficits in dementia. Dev Neuropsychol. 1987;3:13-36.
51. Signoret JL. Batterie d'évaluation de l'efficience mnésique BEM 144. Paris, Elsevier. 1988.
52. Milner B. Interhemispheric differences in the localization of psychological processes in man. Brit Med Bull. 1971;27:272-277.
53. Berg EA. A simple objectie treatment for measuring flexibility in thinking. J Gen Psychol. 1948;39:15-22.
54. De Renzi E, Faglioni P. Normative data and screening power of a shortened version of the Token test. Cortex. 1978;14:41-49.
55. Roth M, Tym E, Mountjoy CQ. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;49:698-709.
56. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to changes. Br J Psychiatry. 1979;134:382-389.
57. A P A (American Psychiatric Association) Committee on Nomenclature, and Statistics. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association; 1994.
58. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology: 1984;34:939-944.
59. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaduci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43:250-260.
60. Bendel RB, Afifi AA. Comparison of stopping rules in forward regression/J. Am. Stat. Ass.. 1977;72:46-53.
61. Morris JC, Fulling K. Early Alzheimer's disease. Diagnostic considerations. Arch Neurol. 1988;45:345-349.
62. Huppert FA, Tym E. Clinical and neropsychological assessment of dementia. Br Med Bull. 1986;42:11-18.
63. Copeland JRMC, Kelleher MJ, Kellet JM. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly. The Geriatric Mental State Schedule. I. Development and reliabibility. Psychol Med. 1976;6:439-449.
64. Davis PB, White H, Price JL, McKeel D, Robins LN. Retrospective post-mortem dementia assessment: validation of a new clinical interview to assist neuropathologic study. Arch Neurol. 1991;48: 613-617.
65. Hofmann A, Rocca WA, Brayne C, Breteler MMB, Clarke M, Cooper B, Copeland JRM, Dartigues JF, Da Silva Droux A, Hagnell O, Heeren TJ, Engedal K, Jonker C, Lindesay J, Lobo A, Mann AH, Mölsä PK, Morgan K, O'Connor DW, Sulkava R, Kay DWK, Amaducci L, for the Eurodem Prevalence Research Group. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Int J Epidemiol. 1991;20:736-748.
66. Yerby MS, Sundsten JW, Larson EB, Wu SA, Sumi SM. A new method of measuring brain atrophy: the effect of aging and its application for diagnosing dementia. Neurology. 1985;35:1316-1320.
67. Patel SV. Pharmacotherapy of cognitive impairment in Alzheimer's disease: a review. J Geriatr Psychiatry Neurol. 1995;8:81-95.
68. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Pirro M, Hanzawa LK. Dementia after stroke is a predictor of long-term survival. Stroke. 1994;25:1915-1919.